biotechnology products Press Release

Title Picture
12/21/2018 - 02:52
(TOKYO: 4519) announced that it filed an application for humanized anti-PD-L1 monoclonal antibody TECENTRIQ
Chugai's picture
Chugai
12/19/2018 - 10:40
Overview of Chugais Research Activities Chugais Seven Strengths
Chugai's picture
Chugai
12/04/2018 - 08:10
(TOKYO: 4519) announced that the primary analysis of the phase III HAVEN 2 study (NCT02795767), evaluating hemophilia A treatment HEMLIBRA
Chugai's picture
Chugai
12/04/2018 - 07:41
TOKYO, December 4, 2018 -- Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced that Chugai Pharma Taiwan Ltd. , a wholly owned subsidiary of Chugai, obtained approval from the Taiwan Food and Drug Administration (TFDA) for Chugais bispecific monoclona
Chugai's picture
Chugai
10/18/2018 - 16:53
Guidelines on Relation with Medical Institutions and Patient Groups
Chugai's picture
Chugai
10/15/2018 - 14:05
Message from the Deputy Chairman of the Board
Chugai's picture
Chugai
10/12/2018 - 08:19
Chugai Releases Disease Awareness Anime about Rheumatoid Arthritis in Multiple Languages Emphasizing Importance of Early Detection/Treatment and Care by Specialists
Chugai's picture
Chugai
09/27/2018 - 05:40
Chugai and Lilly Enter into a License Agreement for Oral GLP-1 Agonist, OWL833
Chugai's picture
Chugai
08/30/2018 - 13:34
Results of Global Phase III Study with Chugai's HEMLIBRA for Hemophilia A without Inhibitors Published in the New England Journal of Medicine
Chugai's picture
Chugai
07/26/2018 - 11:02
Chugai Pharmabody Research Pte. Ltd., Chugais Research Subsidiary
Chugai's picture
Chugai
07/26/2018 - 05:45
Announcement of Business Expansion of Chugai Pharmabody Research Pte. Ltd., Chugais Research Subsidiary
Chugai's picture
Chugai
06/28/2018 - 16:39
Lupin and Mylan Partner to Commercialize Enbrel (Etanercept) Biosimilar
Mylan's picture
Mylan
06/05/2018 - 10:20
Chugais HEMLIBRA Receives Priority Review Status from U.S. FDA for Hemophilia A without Inhibitors
Chugai's picture
Chugai
05/20/2018 - 21:22
Chugai Presents Results of Two Pivotal Phase III Studies
Chugai's picture
Chugai
05/15/2018 - 22:31
Chugais ALK Inhibitor Alecensa Approved for the Treatment of First Line Therapy on ALK-Positive Non-Small Cell Lung Cancer in Taiwan
Chugai's picture
Chugai
04/17/2018 - 04:29
from U.S. FDA for Hemophilia A without Factor VIII Inhibitors
Chugai's picture
Chugai
02/20/2018 - 08:00
Delta Cargo expands Pharma 4 offering to eight locations worldwide
Delta's picture
Delta
01/31/2018 - 19:59
Further Improving Access to Therapies for Non-Small Cell Lung Cancer
Chugai's picture
Chugai
01/30/2018 - 07:35
USDA, FDA Announce Formal Agreement to Bolster Coordination and Collaboration
USDA's picture
USDA
12/20/2017 - 22:29
EU Follows US and Approves Chugais ALK Inhibitor "Alecensa " as First Line Therapy for ALK-Positive Non-Small Cell Lung Cancer
Chugai's picture
Chugai
12/07/2017 - 02:45
Chugais Emicizumab Every Four Weeks Showed Positive Interim Results
Chugai's picture
Chugai
11/29/2017 - 02:33
TWOCELLS and Chugai Announce Performing Surgery of the First Patient in Phase III Trial for gMSC
Chugai's picture
Chugai
11/19/2017 - 23:45
Meets Primary Endpoint in Phase III Study
Chugai's picture
Chugai
11/08/2017 - 04:55
Chugai's ALK Inhibitor "Alecensa " Approved for the Treatment of First Line Therapy on ALK-Positive Non-Small Cell Lung Cancer in the US
Chugai's picture
Chugai
10/04/2017 - 20:23
Results of Preclinical Study Published in Science Translational Medicine
Chugai's picture
Chugai
08/23/2017 - 23:52
Chugais Emicizumab Receives Priority Review Designation by FDA
Chugai's picture
Chugai
06/29/2017 - 01:39
Chugai Deploys RaveX to Modernize Post-Marketing Surveillance
Medidata's picture
Medidata
06/26/2017 - 01:35
Chugais Bispecific Antibody Emicizumab to Present
Chugai's picture
Chugai
06/07/2017 - 00:51
Marketing and Manufacturing Right Transfer of 13 Long-Term Listed Products
Chugai's picture
Chugai
06/06/2017 - 01:10
Data of Chugai's Alecensa Presented at the American Society of Clinical Oncology on Global Phase III ALEX Study
Chugai's picture
Chugai
05/11/2017 - 00:58
Results of the J-ALEX Study for Chugai's Alecensa are Published in The Lancet Online
Chugai's picture
Chugai
04/10/2017 - 02:11
Met Its Primary Endpoint in the ALEX Study
Chugai's picture
Chugai
04/04/2017 - 02:52
A First Approach in the Japanese Pharmaceutical Industry
Chugai's picture
Chugai
04/01/2017 - 01:25
Transfer of Rights to Insomnia Treatment / Anaesthesia Induction Agent Flunitrazepam in Japan
Chugai's picture
Chugai
03/30/2017 - 01:57
Chugai - A*STAR Joint Development Project for Anti-Dengue Virus Antibody Selected as Grant Recipient by the GHIT Fund
Chugai's picture
Chugai
02/27/2017 - 02:45
Chugais ALK Inhibitor Alecensa
Chugai's picture
Chugai
02/21/2017 - 02:28
- Alecensa is Available Now in Japan, the United States and Europe -
Chugai's picture
Chugai
01/06/2017 - 12:32
Federal Biotech Updates Too Little, Too Late
Center for Food Safety's picture
Center for Food...
12/22/2016 - 03:10
PharmaMar and Chugai Pharmaceutical Enter into
Chugai's picture
Chugai
12/21/2016 - 22:42
Chugais Bispecific Antibody Emicizumab for Hemophilia A Meets Primary Endpoint in Phase lll Study
Chugai's picture
Chugai
10/04/2016 - 21:39
Chugais ACTEMRA /RoACTEMRA Receives Breakthrough Therapy Designation from US FDA for Giant Cell Arteritis
Chugai's picture
Chugai
10/03/2016 - 23:14
Chugais Alecensa Receives Breakthrough Therapy Designation from FDA for First-Line Treatment of ALK Positive Non-Small Cell Lung Cancer
Chugai's picture
Chugai
09/30/2016 - 12:43
From designer babies to engineered mosquitoes, advances in genome-editing technologies such as CRISPRCas9 have raised the possibility of
Center for Genetics and Society's picture
Center for Gene...
09/27/2016 - 23:43
Chugai and Maruho Announce License Agreement of Nemolizumab (CIM331),
Chugai's picture
Chugai
08/31/2016 - 22:26
Chugai Transfers the Manufacturing and Marketing Rights of VESANOID to Fuji Pharma
Chugai's picture
Chugai
07/20/2016 - 22:57
Chugai and Galderma Announce Global License Agreement
Chugai's picture
Chugai
07/18/2016 - 11:35
Building a Budget Impact Model: Budget Impact Analysis Training
ISPOR's picture
ISPOR
06/21/2016 - 01:37
Chugai and Maruho Announce the Launch of
Chugai's picture
Chugai
06/01/2016 - 05:10
Chugai Announces License Agreement for Recycling Antibody SA237
Chugai's picture
Chugai